Andrew L. Young

3.4k total citations · 2 hit papers
24 papers, 1.1k citations indexed

About

Andrew L. Young is a scholar working on Hematology, Molecular Biology and Cancer Research. According to data from OpenAlex, Andrew L. Young has authored 24 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Hematology, 9 papers in Molecular Biology and 8 papers in Cancer Research. Recurrent topics in Andrew L. Young's work include Acute Myeloid Leukemia Research (13 papers), Cancer Genomics and Diagnostics (7 papers) and Myeloproliferative Neoplasms: Diagnosis and Treatment (5 papers). Andrew L. Young is often cited by papers focused on Acute Myeloid Leukemia Research (13 papers), Cancer Genomics and Diagnostics (7 papers) and Myeloproliferative Neoplasms: Diagnosis and Treatment (5 papers). Andrew L. Young collaborates with scholars based in United States, Canada and United Kingdom. Andrew L. Young's co-authors include Todd E. Druley, Brenda M. Birmann, Grant A. Challen, Winghing Wong, Daniel S. Fisher, Jamie R. Blundell, Caroline J. Watson, Michael Slade, Brian Duffy and Jun Zou and has published in prestigious journals such as Science, Nature Communications and Blood.

In The Last Decade

Andrew L. Young

22 papers receiving 1.1k citations

Hit Papers

Clonal haematopoiesis harbouring AML-associated mutations... 2016 2026 2019 2022 2016 2020 100 200 300 400

Peers

Andrew L. Young
Clemens Mellink Netherlands
Sarah B. Daly United Kingdom
Shirley Henderson United Kingdom
Andrew L. Young
Citations per year, relative to Andrew L. Young Andrew L. Young (= 1×) peers Anna Jonášová

Countries citing papers authored by Andrew L. Young

Since Specialization
Citations

This map shows the geographic impact of Andrew L. Young's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Andrew L. Young with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Andrew L. Young more than expected).

Fields of papers citing papers by Andrew L. Young

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Andrew L. Young. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Andrew L. Young. The network helps show where Andrew L. Young may publish in the future.

Co-authorship network of co-authors of Andrew L. Young

This figure shows the co-authorship network connecting the top 25 collaborators of Andrew L. Young. A scholar is included among the top collaborators of Andrew L. Young based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Andrew L. Young. Andrew L. Young is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Harrison, Jessica J., Christine Zhang, Andrew L. Young, et al.. (2025). Non-canonical functions of DNMT3A in hematopoietic stem cells regulate telomerase activity and genome integrity. Cell stem cell. 32(8). 1251–1266.e8. 2 indexed citations
2.
Young, Andrew L., et al.. (2024). Spatial Mapping of Hematopoietic Clones in Human Bone Marrow. Blood Cancer Discovery. 5(3). 153–163. 1 indexed citations
3.
Wilson, William C., Andrew L. Young, Eunice S. Wang, et al.. (2024). BIRC5 upregulation enhances DNMT3A-mutant T-ALL cell survival and pathogenesis. PubMed. 1(4). 100040–100040. 1 indexed citations
4.
Young, Andrew L., et al.. (2024). JAK2V617F Mutant MPN Cells Support Parallel Evolution of Independent Leukemic Clones. Blood. 144(Supplement 1). 755–755.
5.
Young, Andrew L., et al.. (2023). Droplet Digital PCR for Oncogenic KMT2A Fusion Detection. Journal of Molecular Diagnostics. 25(12). 898–906. 2 indexed citations
6.
Zhang, Christine, Wentao Han, Andrew L. Young, et al.. (2023). KDM6B protects T-ALL cells from NOTCH1-induced oncogenic stress. Leukemia. 37(4). 728–740. 9 indexed citations
7.
Stowe, T. D., Andrew L. Young, John McLaughlin, et al.. (2022). Cell-Selective Adeno-Associated Virus-Mediated SCN1A Gene Regulation Therapy Rescues Mortality and Seizure Phenotypes in a Dravet Syndrome Mouse Model and Is Well Tolerated in Nonhuman Primates. Human Gene Therapy. 33(11-12). 579–597. 68 indexed citations
8.
Young, Andrew L., Kristine M. Erlandson, Katherine Tassiopoulos, et al.. (2022). Effect of Clonal Hematopoiesis on Cardiovascular Disease in People Living with HIV. Experimental Hematology. 114. 18–21. 10 indexed citations
9.
Watson, Caroline J., Winghing Wong, Andrew L. Young, et al.. (2020). The evolutionary dynamics and fitness landscape of clonal hematopoiesis. Science. 367(6485). 1449–1454. 254 indexed citations breakdown →
10.
Young, Andrew L., et al.. (2019). Clonal hematopoiesis and risk of acute myeloid leukemia. Haematologica. 104(12). 2410–2417. 71 indexed citations
11.
Wong, Winghing, et al.. (2018). Rare Event Detection Using Error-corrected DNA and RNA Sequencing. Journal of Visualized Experiments. 10 indexed citations
12.
Young, Andrew L., et al.. (2017). Utility of Detecting Rare Clonal Hematopoiesis for Predicting Leukemic Transformation in Healthy Individuals. Blood. 130. 304–304. 1 indexed citations
13.
Zou, Jun, Brian Duffy, Michael Slade, et al.. (2017). Rapid detection of donor cell free DNA in lung transplant recipients with rejections using donor-recipient HLA mismatch. Human Immunology. 78(4). 342–349. 48 indexed citations
14.
Kramer, Ashley C., A Kothari, William C. Wilson, et al.. (2017). Dnmt3a regulates T-cell development and suppresses T-ALL transformation. Leukemia. 31(11). 2479–2490. 34 indexed citations
15.
Young, Andrew L., Grant A. Challen, Brenda M. Birmann, & Todd E. Druley. (2016). Clonal haematopoiesis harbouring AML-associated mutations is ubiquitous in healthy adults. Nature Communications. 7(1). 12484–12484. 456 indexed citations breakdown →
16.
Torgerson, Dara G., Tusar Giri, Todd E. Druley, et al.. (2015). Pooled Sequencing of Candidate Genes Implicates Rare Variants in the Development of Asthma Following Severe RSV Bronchiolitis in Infancy. PLoS ONE. 10(11). e0142649–e0142649. 6 indexed citations
17.
Wong, Terrence N., Giridharan Ramsingh, Andrew L. Young, et al.. (2013). The Role Of Early TP53 Mutations On The Evolution Of Therapy-Related AML. Blood. 122(21). 5–5. 9 indexed citations
18.
Ramos, Enrique, Sara E. Chasnoff, Andrew Hughes, et al.. (2012). Population-based rare variant detection via pooled exome or custom hybridization capture with or without individual indexing. BMC Genomics. 13(1). 683–683. 18 indexed citations
19.
Young, Andrew L., Hatice Özel Abaan, Daniel R. Zerbino, et al.. (2010). A new strategy for genome assembly using short sequence reads and reduced representation libraries. Genome Research. 20(2). 249–256. 24 indexed citations
20.
Young, Andrew L., et al.. (2001). GC/MS determination of lipoprotein lipid composition and concentration. Scholarly Commons (University of the Pacific).

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026